(Q38595071)

4 September 2017

title

Molecular basis of alcoholic fatty liver disease: From incidence to treatment (English)

1 reference

Francislaine Aparecida Dos Reis Lívero

4 September 2017

main subject

alcoholic fatty liver

1 reference

based on heuristic

inferred from title

author

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Alexandra Acco

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

29 September 2015

1 reference

4 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

111-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

State costs of excessive alcohol consumption, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Alcohol-attributable cancer deaths and years of potential life lost in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

The relation between different dimensions of alcohol consumption and burden of disease: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Characteristics of alcoholic liver disease and predictive factors for mortality of patients with alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Advances in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

"Second hit" models of alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Alcoholic liver disease: pathogenesis and new therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

21 January 2018

Alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Alcohol and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Alcoholic liver disease: pathogenesis, management, and novel targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

EFFECTS OF PROLONGED ETHANOL INTAKE: PRODUCTION OF FATTY LIVER DESPITE ADEQUATE DIETS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Redefining oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Oxidative stress and antioxidants in hepatic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Free radical mechanisms in immune reactions associated with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Genetics of alcoholic liver disease and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Distribution and kinetics of ethanol metabolism in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Putative role of brain acetaldehyde in ethanol addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Fatty acid regulation of gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Tumor necrosis factor, other cytokines and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Role of cytokines and chemokines in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Current concepts in the pathogenesis of alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

IL-22 is involved in liver regeneration after hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Functions of autophagy in hepatic and pancreatic physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Autophagy and ethanol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Folate deficiency, methionine metabolism, and alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Role of abnormal methionine metabolism in alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Review article: Nutritional therapy in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Hepatic transmethylation reactions in micropigs with alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Role of hypoxia inducing factor-1β in alcohol-induced autophagy, steatosis and liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Hypoxia-inducible factor 2 regulates hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Histologic spectrum of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Pathogenesis, diagnosis, and treatment of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

ALCOHOL: its metabolism and interaction with nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Current efforts and trends in the treatment of NASH

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Vitamin E deficiency induces liver nuclear factor-kappaB DNA-binding activity and changes in related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Influence of vitamin E on alcohol-induced changes in antioxidant defenses in mice liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

A randomized placebo controlled trial of vitamin E for alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Treatment of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Effect of silymarin on liver health and quality of life. Results of a non-interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

FXR: a metabolic regulator and cell protector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Emerging molecular targets for the treatment of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Berberine protects liver from ethanol-induced oxidative stress and steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Biology of interleukin-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

IL-22: a critical mediator in mucosal host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

Subcutaneous vitamin E ameliorates liver injury in anin vivo model of steatocholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12594

21 January 2018

Identifiers

DOI

10.1111/HEPR.12594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26417962%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference